Gene Therapy Startups Gain Traction, as COVID Vaccines Lowered Barrier
Posted on 03/15/2021
ElevateBio is a Cambridge, Mass.-based cell and gene therapy developer. ElevateBio raised US$ 525 million in Series C funding. Matrix Capital Management led, and was joined by SoftBank Vision Fund 2 and Fidelity. Insitro is a South SF-based drug discovery platform. Insitro raised US$ 400 million in Series C funding. CPP Investments (Canada Pension Plan […]
